What is it about?
Cystic Fibrosis (CF) is a genetic disease that manifests in many organs such as the lungs, pancreas and reproductive system, causing various symptoms (e.g. coughing, abdominal pain, lack of energy). As the disease progresses, symptom management requires increasing time and effort which may negatively influence the time to be physically active. Yet, research suggests that a sufficient amount of physical activity (PA) provides specific health benefits (e.g. slower deterioration of the lungs) for people with CF (PwCF). Despite these well-known benefits, little insight exists on the PA level of PwCF compared to healthy peers. Furthermore, several factors may influence someone’s PA behavior. These factors can be general (e.g. socio-demographic factors such as sex) and disease-specific (e.g. how healthy their lungs are, i.e. lung function). This knowledge is essential to fully understand patients’ PA behavior, but, evidence on this topic in PwCF is scarce. Therefore, the present review aims 1) to provide an overview of the PA level of patients with CF compared to healthy peers, and 2) to explore the influencing factors of PA in PwCF. The existing literature was systematically searched which resulted in 46 studies. Sixteen of these studies showed that the CF population is equally active as their healthy peers, but there is a trend towards less high intensity PA in youth with CF. Regarding the influencing factors in PwCF, the following factors were found to be related to PA: quality of life, lung function, (maximal) exercise capacity, bone mineral density, quadriceps force, weekday and experiencing pulmonary exacerbations. To note, it was difficult to interpreter the data as most papers were of low methodological quality. In summary, more high-quality PA research is required in PwCF, particularly follow-up studies that further explore the influencing factors of PA.
Featured Image
Photo by Bruno Nascimento on Unsplash
Read the Original
This page is a summary of: Physical activity and its correlates in people with cystic fibrosis: a systematic review, European Respiratory Review, September 2022, European Respiratory Society (ERS),
DOI: 10.1183/16000617.0010-2022.
You can read the full text:
Contributors
The following have contributed to this page







